Parkinson’s disease: On the threshold of new therapies in an area of high unmet need

Current therapies for Parkinson’s disease treat the symptoms but do not prevent, slow or halt its progression. Investigators are on the cusp of discovery and drug development that will improve current symptomatic treatments, allow for earlier diagnosis, and provide the cure for Parkinson’s that millions desperately seek. Genetic insights, characterization of drug targets and coordination of efforts have brought us closer to a disease-modifying therapy.